Generation of functional adipoids from human induced pluripotent stem cells
- 1Biozentrum, University of Basel Basel, Switzerland
Abstract
Human adipose tissue models are lacking although essential for metabolic research. Traditional primary cell cultures are poorly scalable and unsuitable for drug screening or modeling of genetic disease. Conventional two-dimensional adipocyte cultures cannot withstand the long-term treatment required to mimic chronic conditions such as obesity and insulin resistance. To overcome these limitations, we developed an accessible protocol to produce three-dimensional human induced pluripotent stem cell (hiPSC)-derived adipocyte microtissues, termed adipoids. hiPSC-derived adipoids display long-term stability and viability. Single-nucleus RNA sequencing revealed that adipoids contain mature adipocytes and adipocyte stem/progenitor cells, similar to human adipose tissue. Furthermore, hiPSC-derived adipoids contain unilocular adipocytes, exhibit stimulated lipolysis, and secrete adipokines. Thus, hiPSC-derived adipoids provide a functional, scalable and genetically tractable model to perform large-scale pharmacological screens and to investigate human metabolic disease.
Related
- Generation of four human induced pluripotent stem cell lines derived from patients with corticosteroid-associated central serous chorioretinopathy
- Generation of two human induced pluripotent stem cell lines from patients with hypokalemic periodic paralysis
- Generation and characterization of three human induced pluripotent stem cell lines from patients with Duchenne muscular dystrophy
- Generation of hypoimmunogenic cardiomyocytes from human induced pluripotent stem cells with TAPBP knockout
- GENERATION OF HUMAN ERYTHROID CELLS IN A THREE-DIMENSIONAL MODEL DERIVED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS
BibTeX
@misc{hinte2026generation,
title = {{Generation of functional adipoids from human induced pluripotent stem cells}},
author = {L. C. Hinte and R. Okamoto and S. Jansen and S. E. Spirig and S. Tsiepa and M. Shimobayashi and M. N. Hall},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.30.762496},
url = {https://www.biorxiv.org/content/10.64898/2026.10.30.762496v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Generation of functional adipoids from human induced pluripotent stem cells
AU - L. C. Hinte
AU - R. Okamoto
AU - S. Jansen
AU - S. E. Spirig
AU - S. Tsiepa
AU - M. Shimobayashi
AU - M. N. Hall
PY - 2026
DA - 2026/10/30
PB - bioRxiv
DO - 10.64898/2026.10.30.762496
UR - https://www.biorxiv.org/content/10.64898/2026.10.30.762496v1
AB - Human adipose tissue models are lacking although essential for metabolic research. Traditional primary cell cultures are poorly scalable and unsuitable for drug screening or modeling of genetic disease. Conventional two-dimensional adipocyte cultures cannot withstand the long-term treatment required to mimic chronic conditions such as obesity and insulin resistance. To overcome these limitations, we developed an accessible protocol to produce three-dimensional human induced pluripotent stem cell (hiPSC)-derived adipocyte microtissues, termed adipoids. hiPSC-derived adipoids display long-term stability and viability. Single-nucleus RNA sequencing revealed that adipoids contain mature adipocytes and adipocyte stem/progenitor cells, similar to human adipose tissue. Furthermore, hiPSC-derived adipoids contain unilocular adipocytes, exhibit stimulated lipolysis, and secrete adipokines. Thus, hiPSC-derived adipoids provide a functional, scalable and genetically tractable model to perform large-scale pharmacological screens and to investigate human metabolic disease.
ER -